-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Tuesday's Intraday Session
Share
Listen to the news

Gainers

  • Alaunos Therapeutics (NASDAQ:TCRT) stock moved upwards by 203.8% to $3.19 during Tuesday's regular session. The company's market cap stands at $2.6 million.
  • Picard Medical (AMEX:PMI) stock moved upwards by 25.17% to $14.2. The market value of their outstanding shares is at $23.2 million.
  • Scinai Immunotherapeutics (NASDAQ:SCNI) stock rose 21.98% to $1.42.
  • Apollomics (NASDAQ:APLM) shares rose 21.95% to $26.0. The company's market cap stands at $62.1 million.
  • Cadrenal Therapeutics (NASDAQ:CVKD) stock increased by 19.21% to $1.04. The market value of their outstanding shares is at $3.1 million.
  • Regencell Bioscience (NASDAQ:RGC) stock moved upwards by 15.73% to $8.25. The company's market cap stands at $3.5 billion.

Losers

  • Mobile-health Network (NASDAQ:MNDR) shares fell 46.2% to $1.64 during Tuesday's regular session. The company's market cap stands at $3.6 million.
  • Azitra (AMEX:AZTR) shares decreased by 39.21% to $0.07. The company's market cap stands at $7.1 million.
  • CDT Equity (NASDAQ:CDT) stock fell 31.97% to $0.45.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) shares fell 31.67% to $0.07.
  • Sunshine Biopharma (NASDAQ:SBFM) shares decreased by 23.15% to $0.23. The market value of their outstanding shares is at $1.1 million.
  • Nexalin Technology (NASDAQ:NXL) shares decreased by 19.99% to $2.69. The market value of their outstanding shares is at $3.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending